Joyani Das, PhD, earned her doctoral degree in pharmacology from the Birla Institute of Technology in Mesra, India, and brings over six years of experience in medical research, education, and health communication. She works as a medical writer, creating evidence-based health content for a broad audience. Prior to this, she worked as a health writer at MomJunction, specializing in health and wellness topics related to women and children. She also served as an associate professor, contributing to academic research and mentoring students in pharmacological sciences. Her areas of expertise include medical writing and drug information.
Recent WebMD content from Joyani Das, PhD
- FDA Approves Wegovy as First Once-Weekly Injection for Obesity-Linked Liver Disease
- FDA Approves New Non-Opioid, Once-Daily Bedtime Tablet for Fibromyalgia Pain and Sleep Disturbance
- Brinsupri: First Once-Daily Tablet for Non-Cystic Fibrosis Bronchiectasis
- Hernexeos (Zongertinib) Approved as the First Oral Targeted Treatment for HER2-Mutant Advanced Lung Cancer
- Ajovy Approved as a First-of-Its-Kind Shot for Preventing Migraine in Children and Teens
- Leqvio: New Injectable Option for Lowering Bad Cholesterol Without Statins
- Vizz: New Daily Eye Drop to Improve Age-Related Blurry Near Vision
- Alhemo: A New Daily Injection to Help Prevent Bleeding in Hemophilia A and B
- Empaveli: A New Treatment Option for Rare Immune-Related Kidney Diseases
- New Oral Treatment for Adults and Children With Phenylketonuria: Sephience
- New Oral Option for Children With Low Platelet Counts: Doptelet
- FDA OKs New Steroid-Free Skin Cream for Hand Eczema
- FDA OKs Moderna’s COVID Shot for Kids, With Limits
- FDA Approves First Oral Treatment for Rare Swelling Disorder
- FDA OKs First-of-Its-Kind Lung Cancer Pill
- FDA Greenlights New Treatment for Advanced Blood Cancer
- FDA Approves First Twice-Yearly Shot to Prevent HIV
- FDA OKs New Monthly Treatment for Rare Swelling Disorder
- More Adults Can Now Get Moderna's RSV Shot
- FDA OKs New Next-Gen Pill for Rare Lung Cancer
- FDA Approves New 3-in-1 Combo Pill for High Blood Pressure
- FDA OKs New Shot to Protect Babies Against RSV
- FDA Approves Moderna’s New COVID Vaccine With Restricted Use
- FDA Approves New Treatment for Dry Eye Disease
- FDA OKs First Meningococcal Vaccine for Infants
- FDA OKs Nucala for Hard-to-Treat COPD
- FDA Approves Novavax COVID Vaccine With Restricted Use
- FDA OKs New Treatment for Hard-to-Treat Lung Cancer
- FDA Approves New Oral Drug Combo for Rare Ovarian Cancer
- FDA Approves New Long-Term Treatment for Myasthenia Gravis